Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.95
AVITA Medical, Inc. incurred credit facility of up to $90 million with an affiliate of OrbiMed at the greater of (x) the SOFR rate for such period and (y) 4.00% plus, in either c maturing five years.
- Instrument
- credit facility
- Principal
- up to $90 million
- Counterparty
- an affiliate of OrbiMed
- Rate
- the greater of (x) the SOFR rate for such period and (y) 4.00% plus, in either c
- Maturity
- five years
- Event
- incurrence
Exact text from the filing
The Credit Agreement provides for a five-year senior secured credit facility in an aggregate principal amount of up to $90 million (the “Loan Facility"), of which (i) $40 million was made available on the Closing Date (the “Initial Commitment Amount")
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
AVITA Medical, Inc. reported the quarter ended September 30, 2023 results: revenue $13.5 million. Guidance reaffirmed.
- Period
- the quarter ended September 30, 2023
- Revenue
- $13.5 million
- Guidance
- reaffirmed
- Result
- preliminary results
Exact text from the filing
preliminary commercial revenue was $13.5 million
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 1.0
AVITA Medical, Inc. entered into Credit Agreement with an affiliate of OrbiMed valued at up to $90 million (effective 2023-10-18).
- Action
- entry
- Agreement
- credit facility
- Counterparty
- an affiliate of OrbiMed
- Value
- up to $90 million
- Effective
- 2023-10-18
Exact text from the filing
AVITA Medical, Inc. (the “Company”) entered into a Credit Agreement (the “Credit Agreement”), by and between the Company, as borrower, and an affiliate of OrbiMed as the lender and administrative agent (the “Lender”). The Credit Agreement provides for a five-year senior secured credit facility in an aggregate principal amount of up to $90 million
View on SEC.gov